✦ LIBER ✦

Two-year results of a randomized, phase III comparative trial of telbivudine versus lamivudine in Chinese patients

✍ Scribed by Jia, Ji-Dong; Hou, Jin-Lin; Yin, You-Kuan; Tan, De-Ming; Xu, Daozhen; Niu, Jun-Qi; Zhou, Xia-Qiu; Wang, Yu-Ming; Zhu, Li-Min; Chen, Cheng-Wei; He, Yong-Wen; Ren, Hong; Wan, Mo-Bin; Wu, Shan-Ming; Wang, Qin-Huan; Wei, Lai; Bao, Weibin; Dong, Yuhong; Trylesinski, Aldo

Book ID: 121567099
Publisher: Springer-Verlag
Year: 2013
Tongue: English
Weight: 390 KB
Volume: 8
Category: Article
ISSN: 1936-0533
DOI: 10.1007/s12072-013-9488-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

[497] TWO-YEAR RESULTS OF A PHASE III CO

[497] TWO-YEAR RESULTS OF A PHASE III COMPARATIVE TRIAL OF TELBIVUDINE VS LAMIVUDINE IN CHINESE PATIENTS

✍ J.-D. Jia; J.-L. Hou; Y.-K. Yin; D.-Z. Xu; D. Tan; J. Niu; X.-Q. Zhou; Y. Wang; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 144 KB

Telbivudine versus lamivudine in Chinese

Telbivudine versus lamivudine in Chinese patients with chronic hepatitis B: Results at 1 year of a randomized, double-blind trial

✍ Jinlin Hou; You-Kuan Yin; Daozhen Xu; Deming Tan; Junqi Niu; Xiaqiu Zhou; Yuming 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 179 KB

Chronic hepatitis B and its life-threatening sequelae are highly prevalent in China. There is a need for effective new therapies to suppress hepatitis B virus (HBV) replication and ameliorate liver disease. In this study, we compared the efficacy of telbivudine, a nucleoside analogue, with lamivudin

219 Results of a one-year international

219 Results of a one-year international phase IIB comparative trial of telbivudine, lamivudine, and the combination, in patients with chronic hepatitis B

✍ Ching-Lung Lai; Nancy W.Y. Leung; Eng-Kiong Teo; Florence Wong; Hie-Wan Hann; St 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 151 KB

Results of a Randomized Phase III Trial

Results of a Randomized Phase III Trial of Mirabegron in Patients with Overactive Bladder

✍ Nitti, Victor W.; Auerbach, Stephen; Martin, Nancy; Calhoun, Alaina; Lee, Misun; 📂 Article 📅 2013 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 1022 KB

[516] A RANDOMIZED TRIAL OF SWITCHING TO

[516] A RANDOMIZED TRIAL OF SWITCHING TO TELBIVUDINE VERSUS CONTINUED LAMIVUDINE IN ADULTS WITH CHRONIC HEPATITIS B: RESULTS OF THE PRIMARY ANALYSIS AT WEEK 24

✍ R. Safadi; Q. Xie; Y. Chen; Y.-K. Yin; L. Wei; S.G. Hwang; E. Zuckerman; J.-D. T 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 276 KB

Population (POP) Pharmacokinetics (PK) o

Population (POP) Pharmacokinetics (PK) of Lamivudine (3TC) in HIV Infected Patients: Results from Two Phase III Clinical Trials

✍ Yuen, G.J.; Benoit, S.; Rubin, M. 📂 Article 📅 1996 🏛 Nature Publishing Group 🌐 English ⚖ 156 KB